The goal of this clinical trial is to measure the median effective dose of oxycodone for the treatment of acute pain after thoracoscopic lobectomy. This clinical trial was divided into two groups based on age, Group I (Age \< 65 years old) and Group II (Age ≥65 years old). We used the sequential allocation designed by Dixon. The initial oxycodone dose was set to 0.1 mg/kg.A satisfactory or an unsatisfactory analgesic response of the previous patient determined, respectively, the relative 10% decrease or increase in the dose of oxycodone the next patient received in the same group. The patient before the first crossover point was included as the first case for ED50 estimation in each group.The study was conducted until 7 crossover points were collected
Study Type
INTERVENTIONAL
Allocation
NON_RANDOMIZED
Purpose
PREVENTION
Masking
QUADRUPLE
Enrollment
60
Oxycodone will be administered intravenously 30min before the end of surgery, and Dixon sequential method will be used for the study
The median effective dose
The median effective dose of oxycodone for the treatment of acute pain after thoracoscopic lobectomy
Time frame: 3 minutes after remoal of the endotracheal tube, 30minutes after remoal of the endotracheal tube
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.